SCHEMBL6847664

SCHEMBL6847664

COc1ccc(Cn2nnnc2-c2ccccc2-c2ccc(COC(C)=O)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.52
FEN1 P39748 1/20 0.52
HSD11B1 P28845 1/20 0.47
ALDH1A1 P00352 6/20 0.45
HTT P42858 1/20 0.45
LMNA P02545 1/20 0.45
AKR1C3 P42330 1/20 0.43
MAPT P10636 1/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
POLB P06746 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPK8 P45983 1/20 0.42
MAPK10 P53779 1/20 0.42
P2RX7 Q99572 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6850540 0.91 P2RX7 (0.50) ERCC5FEN1ALDH1A1TSHRHDAC6
SCHEMBL6849923 0.86 P2RX7 (0.50) ERCC5FEN1HSD11B1ALDH1A1TSHR
SCHEMBL6847838 0.86 ERCC5 (0.53) ERCC5FEN1HSD11B1ALDH1A1HTT
SCHEMBL6848952 0.84 NPC1 (0.53) ERCC5FEN1HSD11B1ALDH1A1HTT
SCHEMBL17036968 0.84 P2RX7 (0.47) ERCC5FEN1ALDH1A1TSHRHDAC6
SCHEMBL12098938 0.83 ERCC5 (0.50) ERCC5FEN1HSD11B1ALDH1A1HTT
SCHEMBL12173023 0.83 ERCC5 (0.50) ERCC5FEN1HSD11B1ALDH1A1HTT
SCHEMBL12697045 0.83 P2RX7 (0.44) ERCC5FEN1HSD11B1ALDH1A1HDAC6
SCHEMBL6850685 0.82 ERCC5 (0.49) ERCC5FEN1HSD11B1ALDH1A1HTT
SCHEMBL6849951 0.82 ALDH1A1 (0.47) ERCC5FEN1HSD11B1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530506-B2 Process for production of biphenyl derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-09-10 US disclosed
EP-2502919-A1 PROCESS FOR PRODUCTION OF BIPHENYL DERIVATIVE Mitsubishi Tanabe Pharma Corporation (JP) 2012-09-26 EP disclosed
US-20120232283-A1 PROCESS FOR PRODUCTION OF BIPHENYL DERIVATIVE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-09-13 US disclosed
WO-2011061996-A1 PROCESS FOR PRODUCTION OF BIPHENYL DERIVATIVE 田辺三菱製薬株式会社 (JP) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232283-A1 PROCESS FOR PRODUCTION OF BIPHENYL DERIVATIVE AGTR2, AGTR1, ACE ERCC5 3866/4885FEN1 4663/4885HSD11B1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.